Myungmoon Phar (017180) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.005x

Based on the latest financial reports, Myungmoon Phar (017180) has a cash flow conversion efficiency ratio of 0.005x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩519.72 Million ≈ $352.20K USD) by net assets (₩104.46 Billion ≈ $70.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Myungmoon Phar stock valuation for the company's overall valuation and market capitalisation.

Myungmoon Phar - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Myungmoon Phar's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Myungmoon Phar Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Myungmoon Phar ranked by their cash flow conversion efficiency. Explore cash flow quality index of Myungmoon Phar to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Karolinska Development AB ser. B ST:KDEV	-0.004x
Maniker KO:027740	-0.041x
Concraft Holding Co Ltd TW:4943	0.011x
R.P.P. Infra Projects Limited NSE:RPPINFRA	0.014x
Tugcelik Aluminyum ve Metal IS:TUCLK	-0.073x
Quest Resource Holding Corp NASDAQ:QRHC	0.167x
Sprintex Ltd AU:SIX	-0.039x
Jeongsan Aikang Co.Ltd KQ:022220	-0.044x

Annual Cash Flow Conversion Efficiency for Myungmoon Phar (2010–2025)

The table below shows the annual cash flow conversion efficiency of Myungmoon Phar from 2010 to 2025. View 017180 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩104.46 Billion ≈ $70.79 Million	₩-1.70 Billion ≈ $-1.15 Million	-0.016x	-25.76%
2024-12-31	₩103.12 Billion ≈ $69.88 Million	₩-1.34 Billion ≈ $-906.54K	-0.013x	+77.78%
2023-12-31	₩88.75 Billion ≈ $60.15 Million	₩-5.18 Billion ≈ $-3.51 Million	-0.058x	-201.57%
2022-12-31	₩95.27 Billion ≈ $64.56 Million	₩5.47 Billion ≈ $3.71 Million	0.057x	+477.20%
2021-12-31	₩85.87 Billion ≈ $58.20 Million	₩855.00 Million ≈ $579.42K	0.010x	+105.42%
2020-12-31	₩90.77 Billion ≈ $61.52 Million	₩-16.67 Billion ≈ $-11.30 Million	-0.184x	-400.89%
2019-12-31	₩80.20 Billion ≈ $54.35 Million	₩-2.94 Billion ≈ $-1.99 Million	-0.037x	-129.92%
2018-12-31	₩93.06 Billion ≈ $63.07 Million	₩11.41 Billion ≈ $7.73 Million	0.123x	+55.39%
2017-12-31	₩101.72 Billion ≈ $68.93 Million	₩8.02 Billion ≈ $5.44 Million	0.079x	+33.34%
2016-12-31	₩94.68 Billion ≈ $64.16 Million	₩5.60 Billion ≈ $3.80 Million	0.059x	+172.13%
2015-12-31	₩67.12 Billion ≈ $45.49 Million	₩-5.50 Billion ≈ $-3.73 Million	-0.082x	-16457.33%
2014-12-31	₩73.15 Billion ≈ $49.57 Million	₩-36.23 Million ≈ $-24.56K	0.000x	-101.81%
2013-12-31	₩73.20 Billion ≈ $49.60 Million	₩2.00 Billion ≈ $1.36 Million	0.027x	-28.27%
2012-12-31	₩72.87 Billion ≈ $49.38 Million	₩2.78 Billion ≈ $1.88 Million	0.038x	-10.77%
2010-12-31	₩67.13 Billion ≈ $45.49 Million	₩2.87 Billion ≈ $1.95 Million	0.043x	--

About Myungmoon Phar

KO:017180 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$29.36 Million

₩43.32 Billion KRW

Market Cap Rank

#23948 Global

#1672 in Korea

Share Price

₩1276.00

Change (1 day)

-0.08%

52-Week Range

₩1057.00 - ₩1945.00

All Time High

₩10277.86